InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by GRAYZEL DAVID S., Director. Officer active across 2 companies, notably Aerovate Therapeutics, Inc.. Aggregated, 4 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €308k. Activity tracked since 9 April 2024. The latest transaction was filed on 9 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
11,882 shares@ US$28.15100.0% of flowCommon StockSEC:0001415889-24-010709:0
2,945,453 sharesCommon StockSEC:0001209191-23-048755:0
2,568,165 sharesCommon StockSEC:0001104659-21-089435:0
2,568,165 sharesCommon StockSEC:0001104659-21-089435
4 of 4 declarations
About GRAYZEL DAVID S.
Grayzel David S. is a Director at Aerovate Therapeutics, Inc. In this role, he oversees the company's activities and participates in strategic decision-making. David is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.
